NCT02694783
- Conditions
- Brain Diseases, Central Nervous System Diseases, Central Nervous System Infections, +15 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Polyomavirus Infections
Explore clinical trials studying Polyomavirus Infections. Study availability and eligibility vary by location and protocol.
126 public trials
34 recruiting studies
Polyomavirus Infections trial results
NCT03304639
- Conditions
- Adenocarcinoma, Advanced Merkel Cell Carcinoma, Carcinoma, +21 more
- Locations
-
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
- Alaska Women's Cancer Care Anchorage, Alaska, United States
NCT00120367
- Conditions
- Blood-Borne Infections, Brain Diseases, Central Nervous System Diseases, +26 more
- Locations
-
- Service de Medecine interne et Maladies Infectieuses, Hopital Bicetre Le Kremlin-Bicêtre, France
NCT04453917
- Conditions
- Brain Diseases, Central Nervous System Diseases, Central Nervous System Infections, +15 more
- Locations
-
- CHU Bordeaux Bordeaux, France
- CHU Montpellier Montpellier, France
- CHU de TOULOUSE Toulouse, France
NCT04157985
- Conditions
- Adenocarcinoma, Advanced Solid Tumors, Anal Cancer, +69 more
- Locations
-
- UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
NCT04781309
- Conditions
- Brain Diseases, Central Nervous System Diseases, Central Nervous System Infections, +15 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT03126110
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +82 more
- Locations
-
- The Angeles Clinic and Research Institute Los Angeles, California, United States
- University of Florida Gainesville, Florida, United States
- Karmanos Cancer Institute Detroit, Michigan, United States
- Washington University - Siteman Cancer Center St Louis, Missouri, United States
NCT03599713
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
- Locations
-
- Stanford Cancer Institute Palo Alto, California, United States
- University of California San Francisco Comprehensive Cancer Center San Francisco, California, United States
- University of Colorado Cancer Center Aurora, Colorado, United States
- Georgetown University Hospital Washington D.C., District of Columbia, United States
NCT04242199
- Conditions
- Adenocarcinoma, Adenoma, Advanced Solid Tumor, +67 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Henry Ford Hospital Detroit, Michigan, United States
- Upmc Cancercenter Pittsburgh, Pennsylvania, United States
- Md Anderson Cancer Center Houston, Texas, United States
Completed
Pembrolizumab (MK-3475) as First-line Therapy for Advanced Merkel Cell Carcinoma (MK-3475-913)
NCT03783078
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +15 more
- Locations
-
- Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0006) New York, United States
- Icahn School of Medicine at Mount Sinai ( Site 0004) New York, United States
- Melanoma Institute Australia ( Site 0400) North Sydney, New South Wales, Australia
- Calvary Mater Newcastle ( Site 0402) Waratah, New South Wales, Australia